125 related articles for article (PubMed ID: 9222284)
21. Comparison of two glucocorticoid preparations (deflazacort and prednisone) in the treatment of immune-mediated diseases.
Scudeletti M; Puppo F; Lanza L; Mantovani L; Bosco O; Iudice A; Imbimbo B; Indiveri F
Eur J Clin Pharmacol; 1993; 45 Suppl 1():S29-34. PubMed ID: 8313931
[TBL] [Abstract][Full Text] [Related]
22. Comparison of antitumor activities of 2-chlorodeoxyadenosine and 9-beta-arabinosyl-2-fluoroadenine in chronic lymphocytic leukemia and marrow cells in vitro.
Begleiter A; Verburg L; Ashique A; Lee K; Israels LG; Mowat MR; Johnston JB
Leukemia; 1995 Nov; 9(11):1875-81. PubMed ID: 7475278
[TBL] [Abstract][Full Text] [Related]
23. [Effect of chlorambucil on B-lymphocytes in the peripheral blood of patients with chronic lymphocytic leukemia--study of cellular ultrastructure].
Brajusković G; Marjanović S; Skaro-Milić A
Vojnosanit Pregl; 2003; 60(2):175-80. PubMed ID: 12852160
[TBL] [Abstract][Full Text] [Related]
24. Combination therapy with nucleoside analogs and alkylating agents.
Johnston JB; Verburg L; Shore T; Williams M; Israels LG; Begleiter A
Leukemia; 1994 Apr; 8 Suppl 1():S140-3. PubMed ID: 8152282
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
Olgaard K; Storm T; van Wowern N; Daugaard H; Egfjord M; Lewin E; Brandi L
Calcif Tissue Int; 1992 Jun; 50(6):490-7. PubMed ID: 1525702
[TBL] [Abstract][Full Text] [Related]
26. Cost-Effectiveness Analysis of Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukaemia in Portuguese Patients who are Unsuitable for Full-Dose Fludarabine-Based Therapy.
Paquete AT; Miguel LS; Becker U; Pereira C; Pinto CG
Appl Health Econ Health Policy; 2017 Aug; 15(4):501-512. PubMed ID: 28342061
[TBL] [Abstract][Full Text] [Related]
27. Comparison of growth retarding effects induced by two different glucocorticoids in prepubertal sick children: an interim long-term analysis.
Aicardi G; Milani S; Imbimbo B; Vignolo M; Di Battista E; Gusmano R; Terragna A; Cordone G; Cottafava F; Coppo R
Calcif Tissue Int; 1991 Apr; 48(4):283-7. PubMed ID: 2059880
[TBL] [Abstract][Full Text] [Related]
28. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
[TBL] [Abstract][Full Text] [Related]
29. In vitro drug-induced cytotoxicity predicts clinical response to high-dose chlorambucil in B-cell chronic lymphocytic leukemia.
Callea V; Stelitano C; Callea I; Console G; Brugiatelli M; Morabito F
Haematologica; 1999 Sep; 84(9):863-4. PubMed ID: 10477466
[No Abstract] [Full Text] [Related]
30. Bcl-2 and bax expression and chlorambucil-induced apoptosis in the T-cells and leukaemic B-cells of untreated B-cell chronic lymphocytic leukaemia patients.
Thomas A; Pepper C; Hoy T; Bentley P
Leuk Res; 2000 Oct; 24(10):813-21. PubMed ID: 10996199
[TBL] [Abstract][Full Text] [Related]
31. Chlorambucil resistance in B-cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl-2-expressing subclones.
Pepper C; Thomas A; Hoy T; Bentley P
Br J Haematol; 1999 Mar; 104(3):581-8. PubMed ID: 10086798
[TBL] [Abstract][Full Text] [Related]
32. Homologous recombinational repair vis-à-vis chlorambucil resistance in chronic lymphocytic leukemia.
Bello VE; Aloyz RS; Christodoulopoulos G; Panasci LC
Biochem Pharmacol; 2002 May; 63(9):1585-8. PubMed ID: 12007561
[TBL] [Abstract][Full Text] [Related]
33. Systematic review of the recent evidence for the efficacy and safety of chlorambucil in the treatment of B-cell malignancies.
Lepretre S; Dartigeas C; Feugier P; Marty M; Salles G
Leuk Lymphoma; 2016; 57(4):852-65. PubMed ID: 26308278
[TBL] [Abstract][Full Text] [Related]
34. Role of the TRAIL/APO2-L death receptors in chlorambucil- and fludarabine-induced apoptosis in chronic lymphocytic leukemia.
Johnston JB; Kabore AF; Strutinsky J; Hu X; Paul JT; Kropp DM; Kuschak B; Begleiter A; Gibson SB
Oncogene; 2003 Nov; 22(51):8356-69. PubMed ID: 14614459
[TBL] [Abstract][Full Text] [Related]
35. Past, present and future role of chlorambucil in the treatment of chronic lymphocytic leukemia.
Goede V; Eichhorst B; Fischer K; Wendtner CM; Hallek M
Leuk Lymphoma; 2015 Jun; 56(6):1585-92. PubMed ID: 25219593
[TBL] [Abstract][Full Text] [Related]
36. Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay.
Bosanquet AG; McCann SR; Crotty GM; Mills MJ; Catovsky D
Acta Haematol; 1995; 93(2-4):73-9. PubMed ID: 7543720
[TBL] [Abstract][Full Text] [Related]
37. Chlorambucil cytotoxicity in malignant B lymphocytes is synergistically increased by 2-(morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-mediated inhibition of DNA double-strand break repair via inhibition of DNA-dependent protein kinase.
Amrein L; Loignon M; Goulet AC; Dunn M; Jean-Claude B; Aloyz R; Panasci L
J Pharmacol Exp Ther; 2007 Jun; 321(3):848-55. PubMed ID: 17351105
[TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of a degradation product of deflazacort.
Paulino AS; Rauber G; Deobald AM; Paulino N; Sawaya AC; Eberlin MN; Cardoso SG
Pharmazie; 2012 Jun; 67(6):495-9. PubMed ID: 22822536
[TBL] [Abstract][Full Text] [Related]
39. Long-term remissions with weekly chlorambucil therapy in patients with intermediate-risk chronic lymphocytic leukaemia.
Manoharan A
Br J Haematol; 2002 Sep; 118(4):1193-4. PubMed ID: 12199809
[No Abstract] [Full Text] [Related]
40. Incidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapy.
Callea V; Brugiatelli M; Stelitano C; Gentile M; Nobile F; Morabito F
Leuk Lymphoma; 2006 Nov; 47(11):2314-20. PubMed ID: 17107903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]